RaphaelStrickerMD

PubMed

• 18 citations
  Let's tackle the testing
  Raphael B. Stricker, Lorraine Johnson
  BMJ. 2007-11-15
• 99 citations
  Evidence-based guidelines for the management of Lyme disease.
  Cameron D, Gaito A, Harris N, Bach G, Bellovin S
  Expert Review of Anti-Infective Therapy. 2004-01-01
• 44 citations
  Hematologic malignancy in sickle cell disease: Report of four cases and review of the literature
  Raphael B. Stricker, Charles A. Linker, Timothy J. Crowley, Stephen H. Embury
  American Journal of Hematology. 1986-02-01

Journal Articles

• What about plasma?  
  Stricker RB, Arch Intern Med
• Health care access and burden of care for patients with Lyme disease: A large United States survey.  
  Johnson L, Aylward A, Stricker RB, Health Policy
• Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease.  
  Stricker RB, Green CL, Savely VR, Chamallas SN, Johnson L, Int J Gen Med
• Neisseria subflava endophthalmitis.  
  Stricker RB, Pompilio JK, Axelrod JL, Kochman RS, Newton JC, Am J Ophthal
• Pernicious anemia, 18q deletion syndrome, and IgA deficiency.  
  Stricker RB, Linker CA, JAMA
• Hematologic malignancy in sickle cell disease.  
  Stricker RB, Embury SH, Am J Hematol
• Intracranial bleeding during treatment with hydroxyethyl starch.  
  Damon L, Adams M, Stricker RB, Ries CA, N Engl J Med
• Association of hematologic malignancies with hemoglobinopathies.  
  Stricker RB, Am J Hematol
• Antibodies to thrombin in postsurgical patients.  
  Stricker RB, Corash L, Blood
• CD8 T cells in human immunodeficiency virus infection.  
  Stricker RB, Arch Int Med
• Autoantibody in post-transfusion purpura.  
  Stricker RB, Vox Sang
• Polio vaccines and the origin of AIDS.  
  Elswood BF, Stricker RB, Res Virol
• Polio vaccines and the origin of AIDS: Clarification.  
  Elswood BF, Stricker RB, Medical Hypotheses
• Safety of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease.  
  Stricker RB, Green CL, Savely VR, Chamallas SN, Johnson L, Minerva Med
• Make peer review really anonymous.  
  Stricker RB, Goldberg B, J NIH Res
• Polio vaccines and the origin of AIDS: An update.  
  Stricker RB, Elswood BF, Medical Hypotheses
• Time for change at journals.  
  Stricker RB, Goldberg B, J NIH Res
• Time for peer review reform.  
  Stricker RB, Goldberg B, The Scientist
• Viagra and HAART.  
  Stricker RB, Thomas DG, Brooks JP, South Med J
• Intravenous immunoglobulin therapy for repeated failure of in-vitro fertilization.  
  Stricker RB, Steinleitner A, Fertil Steril
• Carcinogenicity of statins.  
  Stricker RB, Goldberg B., South Med J
• IDSA Lyme Guidelines: Response to Dr. Gershon's Letter.  
  Stricker RB, Johnson, L, South Med J
• Antiphospholipid antibodies in patients with persistent Lyme disease symptoms.  
  Stricker RB, Johnson L, Lupus
• Risk of malignancy associated with Lyme disease: Still up in the air.  
  Stricker RB, Johnson L, Int J Cancer
• Clinical evidence for rapid transmission of Lyme disease following a tickbite: Response to Piesman and Gray.  
  Stricker RB, Hynote ED, Mervine P, . Diagn Microbiol Infect Dis
• Join now to see all

Books/Book Chapters

•  
  Page 187 - 199Stricker RB, Steinleitner A, Winger EEClin Appl Immunol Rev
•  
  Page 133 - 134Stricker RBFuture Microbiol
•  
  Page 1 - 2Stricker RBMicrobe
•  
  Page 2 - 321Stricker RBMicrobe
•  
  Stricker RBHospital News
•  
  Page 1 - 51Stricker RB, Johnson LMicrobe
•  
  Phillips SE, Burrascano JJ, Harris NS, Horowitz R, Smith HA, Stricker RBCape Cod Times
•  
  Page 71 - 157Goldberg B, Stricker RBASM News
•  
  Page 70 - 347Stricker RB, Goldberg BASM News
•  
  Page 1 - 70Stricker RBASM News
•  
  Phillips SE, Bransfield R, Sherr VT, Smith HA, Dickson K, Stricker RB
•  
  Page 69 - 265Stricker RBLyme disease: A potential polymicrobial infection.
•  
  Page 89 - 96Mitsuyasu RT, Stricker RB, Gaynor R.American Society of Hematology
•  
  Page 60 - 62Stricker RBLyme Times
•  
  Page 76 - 491Stricker RBQuart Rev Biol
•  
  Page 45 - 48Stricker RBLyme Times
•  
  Page 40 - 41Stricker RBLyme Times
•  
  Page 117 - 121Epstein WL, Stricker RBAm J Contact Dermatitis
•  
  Page 277 - 282Kiprov DD, Miller RG, Stricker RBTherapeutic Plasmapheresis
•  
  Page 249 - 265Stricker RBHematol Oncol Clin North Am
•  
  Page 345 - 359Stricker RB, Kiprov DDEditors: Imbach P.Academic Press
•  
  Page 1 - 10Stricker RB, Kwiatkowska BJ, Miller RG, Kiprov DDEditors: Jaeger H (ed), Landsberg AL.
•  
  Page 95 - 114Stricker RBEditors: Volberding P, Jacobson MA.Marcel Dekker, New York
• Join now to see all

Abstracts/Posters

• Improved cellular immune function associated with topical dinitrochlorobenzene (DNCB) therapy in HIV disease.
  Stricker RB, Goldberg B, Winger EE, Epstein WL, Clin Immunol
• Human monoclonal cell surface-reactive autoantibodies: An initial characterization of reactivity and specificity.
  Posner MR, Elboim HS, Tumber MB, Stricker RB, SBT Proceedings
• Quantitation of HIV-1 RNA in plasma of asymptomatic, ARC and AIDS patients.
  Zhu YS, Stricker RB, Gong Y, Kiprov DD, Isaacs S, Cimino G, VIII International Conference on AIDS, Amsterdam, Holland
• Treatment of HIV neuropathy with plasmapheresis and intravenous gammaglobulin.
  Kiprov DD, Stricker RB, Miller RG, VIII International Conference on AIDS, Amsterdam, Holland
• A controlled study of lymphocyte immunization in recurrent spontaneous abortion (RSA): The role of antilymphocyte antibodies (ALA).
  Kiprov D, Stricker R, Nachtigall R, Main E, Smith S, Dumlao C, Jacobson A, Garovoy M, Levinson C, Riv Immunol Immunofarm
• Intravenous gammaglobulin (IVIG) treatment of recurrent spontaneous abortion (RSA) associated with combined alloimmune and autoimmune abnormalities.
  Kiprov D, Stricker R, Nachtigall R, Main E, Smith S, Dumlao C, Jacobson A, Garovoy M, Levinson C, Riv Immunol Immunofarm
• Analysis of lymphocyte subsets in HIV-infected patients treated with dinitrochlorobenzene (DNCB).
  Stricker RB, Elswood BF, Goldberg B, Dumlao C, Van Elk J, Berger TG, Epstein WL, IX International Conference on AIDS, Berlin, Germany
• Response to plasmapheresis following failure of intravenous gammaglobulin in patients with myasthenia gravis and Guillain-Barre syndrome.
  Stricker RB, Kwiatkowska BJ, Habis JA, McLeod DE, Kiprov DD, J Clin Apheresis
• Thrombotic microangiopathy complicating renal carcinoma: Report of the first two cases.
  Stricker RB, Minor DR, Kiprov DD, J Clin Apheresis
• Intravenous gammaglobulin (IVIG) treatment of recurrent spontaneous abortion (RSA) associated with combined alloimmune and autoimmune abnormalities.
  Kiprov D, Stricker R, Nachtigall R, Main E, Smith S, Dumlao C, Jacobson A, Garovoy M, Levinson C, J Immunol
• Clinical and immunologic monitoring of HIV-infected patients treated with topical dinitrochlorobenzene (DNCB).
  Stricker RB, Elswood BF, Goldberg B, Henry J, Winger EE, Epstein WL, Tenth International Conference on AIDS, Yokohama, Japan
• Potential benefit of repeated plasma donation in asymptomatic HIV-infected individuals.
  Stricker RB, Youvan TD, McGrath MF, Levy J, J Clin Apheresis
• Potential benefit of repeated plasma donation in asymptomatic HIV-infected individuals with decreased CD4 T-cell counts.
  Stricker RB, Youvan TD, McGrath MF, Levy J, J Invest Med
• Combination antiretroviral therapy and topical immune modulation with dinitrochlorobenzene (DNCB) in HIV disease.
  Stricker RB, Goldberg B, Epstein WL, Blood
• Clinical, immunologic and virologic effects of highly active antiretroviral therapy (HAART) combined with topical dinitrochlorobenzene (DNCB) in HIV disease.
  Stricker RB, Goldberg B, Winger EE, Epstein WL, 12th World AIDS Conference, Geneva, Switzerland
• Pathogenic considerations and prognostic factors in thrombotic thrombocytopenic purpura (TTP).
  Stricker RB, Kiprov DD, J Clin Apheresis
• Decreased CD57 lymphocyte subset in patients with chronic Lyme disease.
  Stricker RB, Winger EE, FASEB J
• Decreased CD57 lymphocyte subset in patients with chronic Lyme disease.
  Stricker RB, Winger EE, Blood
• Update and critical analysis of low-dose intravenous immunoglobulin (IVIG) therapy for immunologic abortion.
  Stricker RB, Steinleitner A, Bookoff CN, Winger EE., Clin Immunol
• . Critical analysis of intravenous immunoglobulin (IVIG) therapy for recurrent spontaneous abortion.
  Stricker RB, Steinleitner A, Bookoff CN, Winger EE, Am J Reprod Immunol
• Normalization of the CD57 natural killer cell subset associated wth prolonged antibiotic therapy in patients with chronic Lyme disease.
  Stricker RB, Winger EE, Clin Immunol
• Clinical and seroepidemiologic characteristics of Babesia WA-1 coinfection in patients with Lyme disease in California.
  Stricker RB, Harris NS, Yong DC, Winger EE, J Invest Med
• Clinical and immunologic evidence for transmission of Lyme disease through intimate human contact.
  Stricker RB, Moore DH, Winger EE, J Invest Med
• Prognostic significance of very low CD57 natural killer cells in patients with chronic Lyme disease.
  Stricker RB, Winger EE, Clin Invest Med
• Efficacy of clarithromycin/cefdinir combination therapy in patients with chronic Lyme disease.
  Stricker RB, Thomas SL, Moore DH, Winger EE, J Invest Med
• Join now to see all

Other

• State of the art: Lyme disease and the legacy of Paul Ehrlich. 
  Stricker RB, Lautin A, Burrascano JJ, Proceedings of the World Ehrlich Conference on Antimicrobial Therapy
  http://www.ehrlich2004.org/index.html
  Nurenberg, Germany
• Appropriateness of Lyme disease testing: An appropriate analysis? 
  Stricker RB, Hall PD, Lautin A, Ann Fam Med
  http://www.annfammed.org/cgi/eletters/2/4/341#1049
• Recognizing Lyme. 
  Stricker RB, New York Times
  http://www.nytimes.com/
• Medical revisionists threaten effective Lyme treatment. 
  Stricker RB, Hartford Courant
  http://www.courant.com/
• Consumer acceptance depends on whether guidelines reflect patient values. 
  Johnson L, Stricker R, Health Affairs blog
  http://content.healthaffairs.org/content/29/7/1400/reply
• Join now to see all